These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2321349)

  • 21. Masked, controlled study to investigate the efficacy of a Staphylococcus intermedius autogenous bacterin for the control of canine idiopathic recurrent superficial pyoderma.
    Curtis CF; Lamport AI; Lloyd DH
    Vet Dermatol; 2006 Jun; 17(3):163-8. PubMed ID: 16674730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of staphylococcal enterotoxins in Staphylococcus pseudintermedius isolates from dogs with pyoderma and healthy dogs.
    Tanabe T; Toyoguchi M; Hirano F; Chiba M; Onuma K; Sato H
    Microbiol Immunol; 2013 Sep; 57(9):651-4. PubMed ID: 23659343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methicillin resistance of staphylococci isolated from the skin of dogs with pyoderma.
    Kania SA; Williamson NL; Frank LA; Wilkes RP; Jones RD; Bemis DA
    Am J Vet Res; 2004 Sep; 65(9):1265-8. PubMed ID: 15478775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of Staphylococcus intermedius from healthy dogs and cases of superficial pyoderma by DNA restriction endonuclease patterns.
    Hesselbarth J; Witte W; Cuny C; Rohde R; Amtsberg G
    Vet Microbiol; 1994 Aug; 41(3):259-66. PubMed ID: 7975151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterisation of Staphylococcus intermedius isolates from canine pyoderma and from healthy carriers by SDS-PAGE of exoproteins, immunoblotting and restriction endonuclease digest analysis.
    Allaker RP; Garrett N; Kent L; Noble WC; Lloyd DH
    J Med Microbiol; 1993 Dec; 39(6):429-33. PubMed ID: 7902443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of skin concentrations of enrofloxacin in dogs with pyoderma.
    DeManuelle TC; Ihrke PJ; Brandt CM; Kass PH; Vulliet PR
    Am J Vet Res; 1998 Dec; 59(12):1599-604. PubMed ID: 9858413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An overview of bacterial skin disease in the dog.
    Ihrke PJ
    Br Vet J; 1987; 143(2):112-8. PubMed ID: 3555694
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of aerobic bacteriologic culture of epidermal collarette specimens in dogs with superficial pyoderma.
    White SD; Brown AE; Chapman PL; Jang SS; Ihrke PJ
    J Am Vet Med Assoc; 2005 Mar; 226(6):904-8. PubMed ID: 15786991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation of Staphylococcus schleiferi from healthy dogs and dogs with otitis, pyoderma, or both.
    May ER; Hnilica KA; Frank LA; Jones RD; Bemis DA
    J Am Vet Med Assoc; 2005 Sep; 227(6):928-31. PubMed ID: 16190591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nasal carriage of Staphylococcus schleiferi from healthy dogs and dogs with otitis, pyoderma or both.
    May ER; Kinyon JM; Noxon JO
    Vet Microbiol; 2012 Dec; 160(3-4):443-8. PubMed ID: 22771206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recurrent pyoderma and its underlying primary diseases: a retrospective evaluation of 157 dogs.
    Seckerdieck F; Mueller RS
    Vet Rec; 2018 Apr; 182(15):434. PubMed ID: 29419485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum thyroxine and triiodothyronine concentrations in canine pyoderma.
    Slade EA; Thompson FN; Lorenz MD; Kemppainen RJ
    J Am Vet Med Assoc; 1984 Jul; 185(2):216-8. PubMed ID: 6746394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization of Staphylococcus intermedius carriage by healthy dogs and comparison of antimicrobial susceptibility patterns to isolates from dogs with pyoderma.
    Hartmann FA; White DG; West SE; Walker RD; Deboer DJ
    Vet Microbiol; 2005 Jun; 108(1-2):119-31. PubMed ID: 15917140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of clindamycin hydrochloride capsules for the treatment of deep pyoderma due to Staphylococcus intermedius infection in dogs.
    Scott DW; Beningo KE; Miller WH; Rothstein E
    Can Vet J; 1998 Dec; 39(12):753-6. PubMed ID: 9861499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of tylosin tablets for the treatment of pyoderma due to Staphylococcus intermedius infection in dogs.
    Scott DW; Miller WH; Cayatte SM; Bagladi MS
    Can Vet J; 1994 Oct; 35(10):617-21. PubMed ID: 7994702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic responsive ulcerative dermatoses in German Shepherd Dogs with mucocutaneous pyoderma.
    Bassett RJ; Burton GG; Robson DC
    Aust Vet J; 2004 Aug; 82(8):485-9. PubMed ID: 15359964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishing a canine superficial pyoderma model.
    Bäumer W; Bizikova P; Jacob M; Linder KE
    J Appl Microbiol; 2017 Feb; 122(2):331-337. PubMed ID: 27891724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial susceptibility of Staphylococcus intermedius and Staphylococcus schleiferi isolated from dogs.
    Vanni M; Tognetti R; Pretti C; Crema F; Soldani G; Meucci V; Intorre L
    Res Vet Sci; 2009 Oct; 87(2):192-5. PubMed ID: 19268332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation of Staphylococcus schleiferi subspecies coagulans from two cases of canine pyoderma.
    Bes M; Guérin-Faublée V; Freney J; Etienne J
    Vet Rec; 2002 Apr; 150(15):487-8. PubMed ID: 11995683
    [No Abstract]   [Full Text] [Related]  

  • 40. Frequency and antimicrobial susceptibility of Staphylococcus species isolated from canine pyodermas.
    Medleau L; Long RE; Brown J; Miller WH
    Am J Vet Res; 1986 Feb; 47(2):229-31. PubMed ID: 3954195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.